DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Brivanib is an investigational drug.
There have been 23 clinical trials for Brivanib. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Carcinoma, Hepatocellular, and Colorectal Neoplasms. The leading clinical trial sponsors are Bristol-Myers Squibb, Gynecologic Oncology Group, and National Cancer Institute (NCI).
Recent Clinical Trials for Brivanib
|A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer||Hunan Cancer Hospital||Phase 1|
|A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC||Zai Lab (Shanghai) Co., Ltd.||Phase 2|
|Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)||Bristol-Myers Squibb||Phase 1|